March 15, 2013 (Vol. 33, No. 6)
Kolltan Pharmaceuticals hired Jane Henderson as svp and CBO. Most recently, she served as vp, business development at ISTA Pharmaceuticals. Previously, Henderson was evp, CFO and CBO of Panacos Pharmaceuticals and served in similar roles at Axerion Therapeutics.
Jane Henderson
Eric Kübler, Ph.D., is now CSO at Hutman Diagnostics…Peter Rehse joined BioFocus as senior director, structural biology…NeoStem appointed Stephen W. Potter to its board of directors…Prosonix added Cécile Miles as CBO…Lumora appointed Jim Reid as chairman.
Prosensa Therapeutics added Larry Bell, M.D., as its vp of regulatory affairs. Dr. Bell has more than 18 years of experience in running regulatory affairs at companies including Merck, Bristol-Myers Squibb, Aventis, and Amgen. Formerly, he was vp and global head of regulatory affairs at GE Healthcare.
Larry Bell, M.D.
Daniel Cato is now president of Bach Pharma…Ignyta elected Jerry Hurst to its executive advisory board…Curis hired Ali Fattaey, Ph.D., as president and COO…Amyris added Zanna McFerson as CBO…Patrick Barnabe, M.D., joined Nano Labs’ strategic advisory board…Prismic Pharmaceuticals named Danilo Casadei Massari to its management team and board of directors.
Ironwood Pharmaceuticals promoted Mark Currie, Ph.D., to svp, CSO, and president of R&D. Previously he served as svp of R&D and CSO at Ironwood. Prior to that, he was vp of discovery research at Sepracor, and served as director of arthritis and inflammation at Monsanto Company.
Mark Currie, Ph.D.
Ann Powell Judge is now svp, human resources at Bristol-Myers Squibb…Insight Genetics promoted Brock Schweitzer, Ph.D., to senior scientist, Rachel Skelton, Ph.D., to regulatory scientist I, and Kasey Lawrence to technology specialist…Pain Therapeutics appointed Saira Ramasastry to its board of directors as an independent director.
Redd&Whyte appointed Sarah Chaudhry as U.K. sales manager. She has over 12 years of experience in sales management within life science equipment companies including Elga Process Water and Sartorius where she supported a range of laboratory systems.
Sarah Chaudhry
Xenon Pharmaceuticals hired Gary J. Bridger, Ph.D., as evp, R&D…BioNJ elected Francois Nader, M.D., as chairman and Al Altomari, Will Lewis, and Shawn Tomasello to its board of trustees…Cellerant hired William Reed, M.D., as vp, clinical development…PURE Bioscience named Dave Pfanzelter to its board of directors.
Alain Herrera, M.D., joined Nanobiotix as a member of its supervisory board. Formerly, he was vp for global oncology business strategy and development and head of the global oncology franchise at Sanofi-Aventis. Prior to that, Dr. Herrera was chairman of Chiron Therapeutics Europe.
Alain Herrera, M.D.
Wayne Hachey, D.O., has joined Protein Sciences as head of government and clinical affairs…Chimerix appointed Ernest Mario, Ph.D., as chairman of its board of directors…OncoSec Medical promoted Veronica Vallejo to CFO…Kemwell Biopharma hired Ninad Deshpanday, Ph.D., as president of R&D.
Proterro named Edi Eliezer as engineering vp. Formerly, he was director, bioprocess technology and engineering at Fluor. Prior to that, he was vp of technology R&D at DuPont; director, bioprocess technology at Aker Kvaerner; and lead process development and manufacturing engineer at Abbott.
Edi Eliezer
Sean P. Nolan joined InterMune as evp and CBO…Cepheid named John Bishop as chairman of its board of directors and Cristina Kepner as lead independent director…Graham Cooper is now CFO at Receptos…Aratana Therapeutics added Don Stitzenberg as vp of manufacturing and Tammy Newbold as vp of chemistry, manufacturing, and controls.
JonEric Pettersson is now manager of commercial development at Insight Genetics. He joined Insight Genetics in 2007 and was previously senior associate of business development. Before that, he was risk management consultant at OmniSure Consulting Group.
Pressure BioSciences appointed Mickey Urdea, Ph.D., to its board of directors…Cecilia Gonzalo joined Essex Woodlands as managing director…InspireMD named Michael Berman to its board of directors…Michael Hammerschmidt is now vp for development at Life Sciences Foundation.
Send your People Announcements to [email protected]
